Potential Cost-Effectiveness of Early Identification of Hospital-Acquired Infection in Critically Ill Patients

Development and use of serial diagnostic testing that reduces the proportion of patients with delays in appropriate antibiotic therapy for hospital-acquired infections could reduce inpatient mortality. The model presented here offers a cost-effectiveness framework for future test development.